This was followed by a
3 week chronic study using commercial MTO bread as the LC n−3
PUFA source. They found that low dose MTO-enriched bread did
improve plasma LC n−3 PUFA status in both the acute and the chronic
study. In other words, the LC n−3 PUFA in the MTO-enriched bread
was bio-available. Liu et al. (2001) studied the effects of daily intake of
a small amount of fish oil in bread, 36 subjects with hyperlipidemia
were randomly divided into three groups: stable fish oil with oat fibre,
control with oat fibre and control with wheat fibre. Phospholipid fatty
acids, triglycerides, cholesterol and malondialdehyde (MDA) were
measured.